Live tape
Top 8, mentions 7d15,986MSFT3,135 mentions▲ +0.09GOOGL2,220 mentions▲ +0.05AAPL2,162 mentions▲ +0.07META2,108 mentions▲ +0.04SNDK1,875 mentions▲ +0.07NVDA1,622 mentions▲ +0.07SPCX1,596 mentions▲ +0.06AMZN1,268 mentions▲ +0.09

Equity · Healthcare

NEO

NeoGenomics, Inc. · NasdaqCM

$14.00 −1.75% 1D Finazon · prior-day close · Jul 24, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of NEO over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $8.99 on 4 May 2026 through $14.00 on 24 July 2026. Finazon · prior-day close.

Market cap $1.8B
52-week range $5.00 – $15.17
Avg volume 735.3K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

NEO insider trades

SEC Form 4 · last 90 days · newest reported trade 15 Jun 2026
Open-market buys 0
Open-market sells 2
Net sold $119K
Non-trade filings 16
Date Insider Type Shares Value
15 Jun 2026 TETRAULT LYNN A. Director Sell 5,307 $59K
09 Jun 2026 TETRAULT LYNN A. Director Sell 5,307 $60K

Showing the 12 most recent of 18 filings in this window. The figures above count all of them.

Compensation mechanics (10 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Jun 2026 Green Marjorie C Director Option exercise 22,964
01 Jun 2026 Gunn Neil Director Option exercise 23,077
01 Jun 2026 KANOVSKY STEPHEN M Director Option exercise 23,077
01 Jun 2026 Kelly Michael Aaron Director Option exercise 23,077
01 Jun 2026 Kenny John P. Director Option exercise 5,893
01 Jun 2026 Perez David Brian Director Option exercise 23,077
01 Jun 2026 TETRAULT LYNN A. Director Option exercise 23,077
01 Jun 2026 Williams Felicia Director Option exercise 23,077
11 May 2026 Stone Warren Pres & Chief Operating Officer Option exercise 5,830
11 May 2026 Stone Warren Pres & Chief Operating Officer Tax withheld 3,783

NEO reported financials

SEC EDGAR XBRL

NEO reported revenue of $727.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$108.0M.

Figure Reported Period
Revenue $727.3M 31 Dec 2025 fiscal year
Net income −$108.0M 31 Dec 2025 fiscal year
Total assets $1.3B 31 Mar 2026 at period end
Total equity $828.8M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

NEO earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2018 Q2 2018 — $68M
31 Mar 2018 Q1 2018 — $63M
30 Jun 2017 Q2 2018 — $62M
31 Mar 2017 Q1 2018 — $57M

Reported figures & scheduled dates · SEC EDGAR filings

NEO institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a NEO position for the quarter ended 31 Mar 2026 — a combined $54.0M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) −21.4% shares 4,164,183 $30.9M
Millennium Management Trimmed −57.3% shares 2,222,757 $16.5M
Citadel Advisors Trimmed −79.8% shares 263,745 $2.0M
Renaissance Technologies New position 254,172 $1.9M
AQR Capital Management Held (±25%) +14.4% shares 167,363 $1.2M
GAMCO Investors Added +525.0% shares 100,000 $742K
Bridgewater Associates New position 91,190 $677K
Tudor Investment Corp Trimmed −88.6% shares 17,820 $132K
Two Sigma Investments Exited

Source: SEC EDGAR 13F filings

NEO fails-to-deliver

SEC CNS data

On 30 Jun 2026, 15,070 shares of NEO failed to deliver (about $215K) — the latest of 4 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Jun 2026 15,070 $215K 0.012%
29 Jun 2026 47,505 $673K 0.036%
26 Jun 2026 788 $11K 0.001%
25 Jun 2026 3,909 $50K 0.003%
18 Jun 2026 265,032 $2.8M 0.204%
17 Jun 2026 391,853 $4.1M 0.301%
16 Jun 2026 27 $299 <0.001%

Source: SEC fails-to-deliver (CNS) data